Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 10/2009

Open Access 01-10-2009 | Breast Oncology

Mastectomies on the Rise for Breast Cancer: “The Tide Is Changing”

Authors: Charles M. Balch, MD, Lisa K. Jacobs, MD

Published in: Annals of Surgical Oncology | Issue 10/2009

Login to get access

Excerpt

In this issue of the Annals are three articles that describe a substantial increase in the number of therapeutic mastectomies for breast cancer and an increased rate of contralateral prophylactic mastectomies.1‐3 These publications reflect a national trend that is most likely the result of multiple factors. Of these, the major influence is a change in patient attitudes and their choices as they contemplate the benefits and risks of an increasing array of surgical options for breast cancer. Simultaneously, they are exposed to better information about future risks of contralateral disease and the increasing trend to have bilateral mastectomies to achieve a cancer treatment benefit, cancer prevention, cosmetically better symmetry of their breasts, and “peace of mind,” all in one surgical procedure. However, these approaches are not for everyone, and it is our burden of responsibility to ensure that patients are properly informed about all their options and know the relative risks and complications so they can be fully informed as we ask them to participate in these complex decisions. …
Literature
1.
Arrington AK, Jarosek SL, Virnig BA, et al. Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer. Ann Surg Oncol. 2009. DOI:10.​1245/​s10434-009-0641-z.
2.
Jones NB, Wilson J, Kotur L, et al. Contralateral prophylactic mastectomy for unilateral breast cancer: an increasing trend at a single institution. Ann Surg Oncol. 2009. DOI:10.​1245/​s10434-009-0547-9.
3.
McGuire KP, Santillan AA, Kaur P, et al. Are mastectomies on the rise? A 13-year trend analysis of the selection of mastectomy versus breast conservation therapy in 5865 patients. Ann Surg Oncol. 2009. DOI:10.​1245/​s10434-009-0635-x.
4.
Reuben BC, Manwaring J, Neumayer LA. Recent trends and predictors in immediate breast reconstruction after mastectomy in the United States. Am J Surg. 2009 [Epub ahead of print].
5.
Carlson GW, Losken A, Moore B, et al. Results of immediate breast reconstruction after skin-sparing mastectomy. Ann Plast Surg. 2001;46:222–8.CrossRefPubMed
6.
Chagpar A, Langstein HN, Kronowitz SJ, et al. Treatment and outcome of patients with chest wall recurrence after mastectomy and breast reconstruction. Am J Surg. 2004;187:164–9.CrossRefPubMed
7.
Howard MA, Polo K, Pusic AL, et al. Breast cancer local recurrence after mastectomy and TRAM flap reconstruction: incidence and treatment options. Plast Reconstr Surg. 2006;117:1381–6.CrossRefPubMed
8.
Tuttle TM, Habermann EB, Grund EH, et al. Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment. J Clin Oncol. 2007;25:5203–9.CrossRefPubMed
9.
Tuttle TM, Jarosek S, Habermann EB, et al. Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ. J Clin Oncol. 2009;27:1362–7.CrossRefPubMed
10.
Herrinton LJ, Barlow WE, Yu O, et al. Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project. J Clin Oncol. 2005;23:4275–86.CrossRefPubMed
11.
Giuliano AE, Boolbol S, Degnim A, et al. Society of Surgical Oncology: position statement on prophylactic mastectomy. Approved by the Society of Surgical Oncology Executive Council, March 2007. Ann Surg Oncol. 2007;14:2425–7.CrossRefPubMed
12.
Guillem JG, Wood WC, Moley JF, et al. ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes. Ann Surg Oncol. 2006;13:1296–321.CrossRefPubMed
13.
Sorbero ME, Dick AW, Beckjord EB, et al. Diagnostic breast magnetic resonance imaging and contralateral prophylactic mastectomy. Ann Surg Oncol. 2009;16:1597–605.CrossRefPubMed
14.
Metcalfe KA, Lubinski J, Ghadirian P, et al. Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group. J Clin Oncol. 2008;26:1093–7.CrossRefPubMed
15.
Yi M, Meric-Bernstam F, Middleton LP, et al. Predictors of contralateral breast cancer in patients with unilateral breast cancer undergoing contralateral prophylactic mastectomy. Cancer. 2009;115:962–71.CrossRefPubMed
16.
Goldflam K, Hunt KK, Gershenwald JE, et al. Contralateral prophylactic mastectomy. Predictors of significant histologic findings. Cancer. 2004;101:1977–86.CrossRefPubMed
17.
Litton JK, Westin SN, Ready K, et al. Perception of screening and risk reduction surgeries in patients tested for a BRCA deleterious mutation. Cancer. 2009;115:1598–604.CrossRefPubMed
18.
Joslyn SA. Patterns of care for immediate and early delayed breast reconstruction following mastectomy. Plast Reconstr Surg. 2005;115:1289–96.CrossRefPubMed
19.
Geiger AM, West CN, Nekhlyudov L, et al. Contentment with quality of life among breast cancer survivors with and without contralateral prophylactic mastectomy. J Clin Oncol. 2006;24:1350–6.CrossRefPubMed
20.
Frost MH, Slezak JM, Tran NV, et al. Satisfaction after contralateral prophylactic mastectomy: the significance of mastectomy type, reconstructive complications, and body appearance. J Clin Oncol. 2005;23:7849–56.CrossRefPubMed
21.
Tercyak KP, Peshkin BN, Brogan BM, et al. Quality of life after contralateral prophylactic mastectomy in newly diagnosed high-risk breast cancer patients who underwent BRCA1/2 gene testing. J Clin Oncol. 2007;25:285–91.CrossRefPubMed
Metadata
Title
Mastectomies on the Rise for Breast Cancer: “The Tide Is Changing”
Authors
Charles M. Balch, MD
Lisa K. Jacobs, MD
Publication date
01-10-2009
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 10/2009
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-009-0634-y

Other articles of this Issue 10/2009

Annals of Surgical Oncology 10/2009 Go to the issue

Healthcare Policy and Outcomes

Multidisciplinary Cancer Conferences: Identifying Opportunities to Promote Implementation

Breast Oncology

Preoperative Chemotherapy and Potential Impact on Re-Excision for Early Breast Cancer

Translational Research and Biomarkers

Survival Among Patients with Platinum Resistant, Locally Advanced Non-Small Cell Lung Cancer Treated with Platinum-Based Systemic Therapy

Hepatobiliary Tumors

Significance of Alpha-Fetoprotein and Des-γ-Carboxy Prothrombin in Patients with Hepatocellular Carcinoma Undergoing Hepatectomy

Gastrointestinal Oncology

Pancreatic Cystic Neoplasm: The Role of Cyst Morphology, Cyst Fluid Analysis, and Expectant Management

Translational Research and Biomarkers

Prognostic Significance of Vascular Endothelial Growth Factor in Squamous Cell Carcinomas of the Tonsil in Relation to Human Papillomavirus Status and Epidermal Growth Factor Receptor